Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04360044 | Nov 2020 → Feb 2023 | migraine disorder | University of California, San Diego | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04360044 ↗ |
| Route | Inhaled | “Inhaled cannabis will be administered using a portable vaporization system” NCT04360044 ↗ |